$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-23-005773 Act: 34 Size: 363 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-23-005641 Act: 34 Size: 233 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-23-005609 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-005536 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000897069-23-001042 Act: 34 Size: 50 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000897069-23-001044 Size: 28 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-23-003311 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-23-003312 Act: 34 Size: 233 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-23-003077 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-23-003078 Size: 5 KB 网页链接